Sylvia Fitting Selected Research

Trans-Activators (Trans-Acting Factor)

1/2021	Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat.
10/2018	Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.
1/2017	Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.
4/2010	Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia Fitting Research Topics

Disease

11	Neurocognitive Disorders (Clerambault Syndrome) 01/2022 - 08/2012
8	Inflammation (Inflammations) 06/2022 - 11/2011
8	Infections 01/2021 - 04/2010
5	Opioid-Related Disorders (Opiate Addiction) 01/2016 - 07/2012
4	Chronic Disease (Chronic Diseases) 01/2021 - 01/2016
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 09/2008
2	Neuroinflammatory Diseases 01/2021 - 11/2020
2	Disease Progression 11/2020 - 11/2011
2	Pain (Aches) 11/2020 - 01/2015
2	Wounds and Injuries (Trauma) 01/2017 - 06/2012
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 01/2016
2	Cognitive Dysfunction 01/2016 - 09/2014
2	Neuralgia (Stump Neuralgia) 01/2016 - 08/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	HIV Infections (HIV Infection) 02/2015
1	Breast Neoplasms (Breast Cancer) 02/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2012
1	Coinfection 11/2011
1	Substance-Related Disorders (Drug Abuse) 09/2010
1	Encephalitis (Encephalitis, Rasmussen) 04/2010
1	Body Weight (Weight, Body) 09/2008

Drug/Important Bio-Agent (IBA)

6	Opioid Analgesics (Opioids)IBA 12/2020 - 09/2010
5	EndocannabinoidsIBA 01/2022 - 01/2016
5	Opiate AlkaloidsIBA 11/2020 - 04/2010
5	Proteins (Proteins, Gene)FDA Link 02/2015 - 09/2008
4	Trans-Activators (Trans-Acting Factor)IBA 01/2021 - 04/2010
4	Morphine (MS Contin)FDA LinkGeneric 11/2020 - 11/2011
2	Viral ProteinsIBA 01/2021 - 03/2013
2	CannabinoidsIBA 01/2021 - 01/2021
2	LigandsIBA 11/2020 - 01/2015
2	CytokinesIBA 11/2020 - 11/2011
2	ChemokinesIBA 11/2020 - 01/2014
2	Peptides (Polypeptides)IBA 01/2015 - 06/2012
2	Opioid Receptors (Opioid Receptor)IBA 01/2015 - 12/2011
1	Cocaine (Cocaine HCl)IBA 06/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2021
1	EnzymesIBA 01/2021
1	Monoacylglycerol LipasesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA 11/2020
1	LipidsIBA 11/2020
1	Amino Acids FDA Link 11/2020
1	Progesterone FDA LinkGeneric 10/2019
1	NeurotoxinsIBA 10/2018
1	CalciumIBA 01/2017
1	Pharmaceutical PreparationsIBA 02/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Opioid Peptides (Opioid Peptide)IBA 01/2015
1	Doxycycline (Periostat)FDA LinkGeneric 08/2012
1	Dynorphins (Dynorphin)IBA 06/2012
1	Heroin (Diamorphine)IBA 11/2011
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2011
1	Free RadicalsIBA 11/2011
1	UbiquitinIBA 11/2011

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2012